--- title: "About" description: "Amass connects papers, trials, patents and regulatory records in one scientific intelligence layer. Meet the scientists, engineers and board members behind it." url: https://amass.tech/about --- # About About Amass # Built for scientific work that runs on evidence. The evidence behind a scientific decision sits in too many systems. Amass connects papers, trials, patents and regulatory records in one scientific intelligence layer, so your team can search, verify and reuse it without losing the source trail. Mission ## Scientific evidence you can trace and reuse. Life science decisions are only as good as the evidence behind them. That evidence is scattered across papers, patents, trials, regulatory sources and internal documents. Amass brings it into one layer. Every answer links back to its source, so researchers, investors, developers and strategy teams work from the same evidence. Your people make the call. Amass supplies the evidence underneath. 43M+papers in BioMedCore 8\*Cores in the app 2022Founded CopenhagenDenmark How we got here ## From biomedical search to scientific intelligence infrastructure Amass started from one problem: life science teams make important decisions from evidence scattered across many sources. We began with biomedical retrieval: searching the literature with precision and a source trail. Amass has since grown into a scientific intelligence layer that connects evidence sources, structures them into workflows and links every answer to its source. Teams use it for research, due diligence, competitive intelligence, portfolio monitoring, target evaluation and scientific strategy. The \*Cores ### Eight data layers underneath - BioMedCoreBiomedical literature and citations. - ScholarCoreScholarly literature across every discipline. - PatentCorePatents, claims, families and ownership. - RegulatoryCoreFDA, EMA and regulatory documents. - DrugCoreDrugs, molecules and modalities. - TrialCoreClinical trials, sponsors and endpoints. - GeneCoreHuman genes, targets, and druggability. - WebCoreReal-time company, market and conference news. App, API and MCP The app has all eight \*Cores. The API and the MCP serve six of them to your own code and AI tools. How we work ## How Amass handles the evidence ### Sources before answers Amass retrieves the source material first, then structures it, synthesizes it and reasons over it. ### Built for life science data Publications, patents, clinical trials, regulatory sources, web data and internal documents, worked on together. ### Traceable by default Every answer, workflow and output links back to its source, so your team can review, verify and reuse the evidence. Founders ## Scientific depth and commercial execution ### Alexander Junge Co-Founder & CTO Bioinformatics PhD and former Novo Nordisk data scientist. Built the Amass data engine from the ground up, combining biomedical retrieval, scientific data infrastructure and applied AI for life science workflows. PhD BioinformaticsNovo Nordisk18,000+ citationsAI/MLScientific retrieval ### Henrik Jensen Co-Founder & CEO Commercial and organizational lead with experience scaling digital products, fundraising, partnerships and go-to-market. Previously built and exited product-led companies and advised life science and technology organizations. CEO / GTMIPO experienceExit experienceVC / fundraisingLife science strategy Team ## People who have worked inside the problem ### Jörn Petersen AI & Data Engineer Founding engineer behind Novo Nordisk's BraiNN biomedical knowledge graph. Builds the data pipelines, retrieval systems and scientific infrastructure behind Amass. Novo Nordisk BraiNNBiomedical knowledge graphsIBM Watson Health ### René Bischoff Platform and Infra Engineer Full-stack and infrastructure engineer. First engineer at Pleo and built their infrastructure from the ground up. Builds the platform layer that makes Amass reliable in production. Platform EngineerInfrastructureAPI and MCP ### Lluís Colomer Coll AI Engineer Leads development of Amass agents and applied AI workflows. Focused on model orchestration, research workflows and production-grade scientific agents. MSc Human-Centered AIAmass Agents lead ### Emil Cronval GTM Engineer Builds the bridge between product, operations and go-to-market. Owns automation, customer workflows and internal systems that help Amass move faster. AI GTMOperationsAutomationSales workflows ### Heidi Noddeland Business Development Life science commercial strategy and partnerships. PhD in pharmaceutical sciences with experience in pharma, biotech and innovation consulting. PhD Pharmaceutical SciencesLEO PharmaBioInnovation / consultingPartnerships ### Niels Andersen Product & UX Strategy Shapes product direction and user-facing workflows. 20 years of product strategy and design across enterprise and startup environments. Product strategyUXEnterprise softwareLife science workflows ### Kris Modig Scientific Solutions, Enterprise Growth Lead Helps life science organizations put the Amass scientific data layer to work in their research and decision-making. Five years bridging science and data in antibody and biologics discovery, most recently at Benchling and before that at PipeBio. BenchlingPipeBio We're hiring ### ML / Research Engineer Work on retrieval, grounding and scientific reasoning across eight \*Cores, from 43M+ papers to 170M+ patents. You know ML well and ship to production. Copenhagen, on-siteFull-time [See the role→](https://amass.tech/careers) We're hiring ### Platform Engineer Scale the infrastructure that serves the \*Cores and the API to research teams. Backend, data and distributed systems. Copenhagen, on-siteFull-time [See the role→](https://amass.tech/careers) Open application ### Don't see your role? If you work in life science, infrastructure or AI, write to us. All disciplines [Get in touch→](mailto:hello@amass.tech) Board ## The board behind the strategy The board oversees governance and strategy. ### Dr. Christian Thirion Chairman Founder and MD of SIRION Biotech GmbH, a Munich-based biotech firm recognized as a leader in viral vector development and cell modeling for preclinical research (sold to Revvity). Also serves as board member at Lysomab and Hervolution. ### Tommy Ahlers Board member Partner at Giant Ventures. Former Danish Minister for Science and Higher Education and MP. Founded/built ZYB and Podio (exit to Vodafone and Citrix) and chair of Peakon and Lix. ### Bodil Sidén Board member General Partner at KOST Capital, an early-stage VC investing in food and bioeconomy-driven innovation. Former Partner at blq invest, backing early-stage ventures like Ingrid, Bower and Hydda. Backed by ## Our investors Amass is backed by bio, tech and pharma investors. ## Build scientific intelligence infrastructure with us. If you want to work on the evidence behind scientific decisions, see the open roles or write to us. [See open roles →](https://amass.tech/careers)[Get in touch →](mailto:hello@amass.tech) Data No training on your data Hosting EU-hosted, enterprise Isolation Tenant-isolated by architecture Certification ISO 27001, SOC 2, NIS2: in motion